The study confirms long-term DAPT as an optimal treatment option for ACS patients following PCI, reducing ischemic events without increasing bleeding. Extended DAPT was associated with a lower risk of major cardiovascular events without an increase in bleeding events in high-risk patients.
A new study shows that a potassium ferrate hemostatic patch reduces the time to hemostasis after cardiac catherization, making it safer and faster to remove compression bands. This finding has the potential to change practice and enable same-day discharge protocols for patients.
A new study reveals African Americans under 45 with CAD have a higher incidence of obesity, drug abuse, alcohol abuse, and mental health conditions like depression. These non-traditional risk factors contribute to the complex burden of disease in this patient population.
Two new studies provide new insights for treating cardiogenic shock, a rare and life-threatening condition where the heart stops pumping enough blood. The studies confirm the accuracy of the SCAI shock stage classification system and show that early use of mechanical circulatory support improves patient outcomes.
The Society for Cardiovascular Angiography and Interventions has released updated consensus guidelines on best practices in cardiac catheterization laboratories. The new recommendations focus on patient-centered approaches, staff qualifications, and quality metrics to optimize outcomes. The document covers topics such as pre-procedure ...
During the pandemic, a 70% decrease was observed in heart attack patients seeking care, with those receiving treatment experiencing more severe symptoms due to delays. The study underscores the importance of early treatment and public education on cardiac care.
The Melody transcatheter pulmonary valve (TPV) has demonstrated favorable outcomes for long-term function, safety, and efficacy in congenital patients. At 10-year follow-up, the study found high freedom rates from all-cause mortality, surgical reintervention, and catheter intervention.
The Harmony TPV Pivotal Trial demonstrated favorable outcomes for the use of TPV device in patients with severe pulmonary regurgitation. The trial showed high procedural success, safety, and favorable device performance, with 100% freedom from procedure-related mortality at 30 days.
A large randomized study found that patients undergoing cardiac catheterization can eat prior to the procedure without increasing complications or costs. The study challenges traditional fasting protocols and could lead to more patient-centered care.
A novel study uses optical coherence tomography to predict hemodynamic relevance of coronary lesions, reducing need for pressure wire and potentially saving patient risk and healthcare expenses. OCT parameters showed significant correlation with fractional flow reserve values.
Icosapent ethyl significantly reduces first and subsequent revascularizations, including coronary stenting and cardiac bypass surgery, in statin-treated patients with elevated triglycerides. The study found a 34% reduction in first revascularization events and higher reductions in subsequent events among statin-stabilized patients.
A novel telemedicine-based network has been established to provide remote guidance to over 100 million STEMI patients in Brazil, Colombia, Mexico, and Argentina. The program has shown significant benefits, including reduced mortality by 55% and cost savings of $291 million.
The TWILIGHT trial found that bioabsorbable polymer DES (BP-EES) performed similarly to durable polymer DES (DP-DES) in high-risk patients undergoing PCI. The study also showed a lower frequency of prior MI in BP-EES patients compared to DP-DES patients.
The SCAI has released an expert consensus statement outlining recommendations for the management of out-of-hospital cardiac arrests. The guidelines emphasize a continuum of care from pre-hospital to hospital and post-hospital phases to enhance survival and quality of life.
Researchers conducted a two-center trial of autologous CD34+ cell therapy in 20 NOCAD patients with persistent angina, showing significant improvement in coronary flow reserve, angina frequency, and quality of life. The results demonstrate the potential of CD34+ cell therapy as a promising therapy for CMD patients with angina and NOCAD.
A new study has shown that patients with intermediate left main coronary artery disease are at a higher risk of cardiovascular events compared to those without the condition. The ISCHEMIA trial sub study found no significant difference in outcomes between invasive and conservative strategies for these patients.
The Society for Cardiovascular Angiography and Interventions has released comprehensive guidelines for selecting devices used in aorto-iliac arterial interventions. The recommendations aim to provide clinicians with practical guidance based on comparative effectiveness data.
The Society for Cardiovascular Angiography and Interventions (SCAI) has released a position statement on optimal percutaneous interventional therapy for complex coronary artery disease. The guidelines address the challenges of treating patients with advanced age, frailty, comorbidities, and compromised hemodynamic status.
The Society for Cardiovascular Angiography and Interventions (SCAI) has issued a position statement on the performance of percutaneous coronary intervention (PCI) in ambulatory surgical centers (ASCs). The guidelines recommend diagnostic procedures, procedural standards, and operator standards for ASCs, emphasizing patient suitability ...
The SCAI, ACC, and ACEP released a consensus statement providing recommendations for systematic care of AMI patients during the COVID-19 pandemic. The document outlines strategies to minimize exposure to the virus while ensuring healthcare worker safety.
The Society for Cardiovascular Angiography and Interventions has issued recommendations on adult congenital cardiac interventional training, focusing on eligibility, training environment, and procedural volume. The guidelines suggest a minimum of 150 ACHD catheterization cases for trainees to participate in as primary or first assistant.
The ISCHEMIA trial found that early revascularization doesn't lower rates of death or heart failure in stable patients, but improves quality of life and reduces spontaneous heart attacks. The study confirms the effectiveness of PCI in relieving angina symptoms.
A new shock classification scheme has been validated in a retrospective study analyzing over 10,000 cardiac intensive care patients, revealing a stepwise increase in unadjusted CICU and hospital mortality with each successive SCAI shock stage.
The Society for Cardiovascular Angiography and Interventions (SCAI) has awarded its highest designation, Master Interventionalists of SCAI (MSCAI), to seven outstanding interventional cardiologists. These individuals have demonstrated excellence in invasive/interventional cardiology, clinical care, innovation, publication, and teaching.
A new study found that IVUS-guided drug-eluting stent implantation significantly reduces target vessel failure and improves quality of life in chronic kidney disease patients. The treatment approach was compared to traditionally used angiography-guidance, showing better outcomes at the 12-month mark.
A novel therapeutic approach occluding the superior vena cava shows promise in reducing pressure and volume in heart failure patients. The treatment improves cardiac filling pressures and function without affecting systemic blood pressure or output.
A novel non-hyperemic pressure ratio (NHPR) index, combined with fractional flow reserve (FFR), accurately predicts percutaneous coronary intervention (PCI) success. The study found a significant linear correlation between NHPR and FFR, with a Pd/Pa value of <0.90 demonstrating excellent diagnostic performance against FFR.
A global registry demonstrates FFR provides valuable additional information after angiography, resulting in treatment changes in over a third of patients. The study showed more patients were assigned to medical management and CABG post-FFR than post-angiography.
The BRAVO-3 clinical trial found ProGlide VCD to be associated with lower rates of vascular complications and shorter hospitalizations after TAVR. The study showed ProGlide offered fewer complications compared to ProStar XL, with lower rates of acute kidney injury.
A new registry study finds that clinicians and patients have different perceptions of atrial fibrillation risk, leading to inconsistent treatment decisions. The AVIATOR 2 registry shows the need for better tools to quantify risk and improve patient outcomes.
A new study has established a nationwide treatment protocol for cardiogenic shock, saving 72% of patients' lives. The protocol, which emphasizes invasive hemodynamic monitoring and mechanical circulatory support, was tested in 35 sites across the US.
A new minimally invasive treatment option has been shown to dramatically lower rates of low-density lipoprotein (LDL) cholesterol in patients following a heart attack. The procedure, called LDL-apheresis, decreases LDL levels by 50-80 percent in two to three hours.
The Saranas Early Bird Bleed Monitoring System has been shown to detect bleeding events during endovascular procedures with a high degree of accuracy, reducing the risk of complications and mortality. The device was tested in 60 patients and detected bleeding in 63% of cases, with no device-related complications reported.
A new five-stage system defines cardiogenic shock based on narrative patient descriptions, physical findings, and biochemical/hemodynamic markers to facilitate rapid assessment and communication between providers. The consensus aims to standardize vocabulary, recognize risk for adverse outcomes, and inform interventions.
The statement emphasizes that high-quality CCL care should not be limited by fiscal concerns, and provides recommendations for balancing revenue and expenses. It also highlights the importance of aligning leadership, strategy, organization, processes, personnel, and culture to optimize outcomes and efficiency.
The SCAI-WIN program aims to increase female participation in interventional cardiology. Megha Prasad has been selected for a $100,000 fellowship to develop complex and high-risk intervention skills.
A new study developed a novel risk tool to predict 30-day readmission rates in patients undergoing transcatheter aortic valve replacement (TAVR). The tool calculates a score based on several variables, including chronic kidney disease, anemia, and discharge disposition, with a c-statistic of 0.63.
A contemporary real-world analysis of culprit vessel-only intervention (CVI) versus multivessel intervention (MVI) in patients with acute myocardial infarction (AMI) and cardiogenic shock (CS) found lower mortality rates for CVI. The study, presented at the Society for Cardiovascular Angiography and Interventions 2018 Scientific Sessio...
A significant update to the PROGRESS-CTO International Registry reveals successful outcomes of Chronic Total Occlusion Percutaneous Intervention (CTO PCI) for over 3,000 patients. The study found high success rates with acceptable complications, supporting its use in experienced centers.
The AVIATOR 2 international registry found significant discrepancies between physician-perceived risks and calculated scores for stroke, ischemic risk, and bleeding in patients with AF undergoing PCI. The study used a novel smartphone-based survey to capture physician and patient perspectives on antithrombotic therapies after PCI.
The PERSPECTIVE trial presents a comprehensive review of the safety, efficacy, and durability of Zotarolimus-Eluting Stents in treating chronic total occlusion. Treatment with second-generation drug-eluting stents resulted in lower occurrence of adverse events compared to previous DES trials.
A new study analyzing patients with mixed drug abuse and endocarditis found a significant increase in hospitalizations over the last decade. The study estimated substantial healthcare costs, with a total of $17.3 million billed by the hospital in 2015 alone.
A new study presents promising results using 3D printing technology to predict and prevent paravalvular leaks in patients undergoing TAVR. The study's findings suggest that personalized valve placement and size can lower the risk of leaks, improving patient outcomes.
Researchers found a significant increase in hospitalizations for aortic dissection and ST-Elevation Myocardial Infarctions (STEMI) during winter months. The studies, presented at the SCAI 2018 Scientific Sessions, used the Nationwide Inpatient Sample database to analyze seasonal variations in cardiac-related hospitalizations.
A new study has found that patients who undergo TAVR procedure and stay in the hospital for more than 72 hours may be at risk of negative short and long-term outcomes. The study identified independent predictors of both early and delayed discharge, with delayed discharge associated with worse one-year outcomes.
The Preserve clinical trial has revealed significant benefits of oral acetylcysteine and sodium bicarbonate in reducing cardiovascular complications. Researchers analyzed data from a large cohort of high-risk patients who underwent PCI, demonstrating the efficacy of this treatment approach.
The MitraClip device has demonstrated improved echocardiogram measurements and six-minute walk test outcomes, with significant reductions in left ventricle volume and NYHA classification. The study also showed substantial improvement in quality of life outcomes for patients with mitral valve regurgitation.
A new study reveals that treating psoriasis with biologic therapy can significantly reduce coronary plaque. The research found that the treatments not only decreased plaque volume but also reduced inflammation, leading to fewer characteristics prone to rupture and cause a heart attack over time.
The Society for Cardiovascular Angiography and Interventions (SCAI) has released new guidelines for selecting specific categories of devices in endovascular therapy. The guidelines provide device-focused recommendations based on a review of comparative effectiveness data, including safety and efficacy of femoral-popliteal devices.
The Society for Cardiovascular Angiography and Interventions has updated its consensus guidelines to allow for flexibility in length of stay after percutaneous coronary intervention (PCI), prioritizing patient-centered care. The new guidelines assess readiness for discharge along three lines: procedural, patient, and programmatic factors.